Stay updated on TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page.

Latest updates to the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page
- Check3 days agoChange DetectedAdded the revision tag Revision: v3.5.3 at the bottom of the page, replacing Revision: v3.5.2. This indicates a minor version update to the page's underlying system rather than a change to the study content or results.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedNaples, Italy, 80131 was added to locations and Napoli, Italy, 80131 was removed; revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated to v3.4.3; the previous revision v3.4.2 is no longer listed.SummaryDifference0.0%

- Check76 days agoChange DetectedAdded Gastric cancer topic and a new external resource link to the Genetic and Rare Diseases Information Center. Page revision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check83 days agoChange DetectedA full citation for the TAGS trial (Lancet Oncol. 2018) was added to Publications, and the record version was updated from v3.4.0 (with an erratum) to v3.4.1.SummaryDifference0.0%

Stay in the know with updates to TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page.